Sopharma registered 16% YoY decline in Sep’24 unconsolidated sales, including 15% YoY decrease in domestic sales, and 16% YoY drop in exports. 9-mo 2024 sales were down by 8% YoY due to 15% YoY decrease of exports, despite 5% increase of domestic sales.